Koers HBL - Hadasit Bio-Holdings Ltd TEL AVIV STOCK EXCHANGE
Aandelen
HDST
IL0010954050
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 7,43 mln. 1,95 mln. 1,82 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -31 mln. -8,13 mln. -7,61 mln. | Nettowinst (verlies) 2023 | -29 mln. -7,61 mln. -7,12 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 12,93 mln. 3,39 mln. 3,17 mln. | Nettoliquiditeiten 2023 | 6,46 mln. 1,69 mln. 1,59 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-0,46
x | K/w-verhouding 2023 |
-0,25
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 25% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yoram Azulai
CEO | Chief Executive Officer | 63 | 20-09-15 |
Tamar Raz
CHM | Chairman | 60 | 18-05-14 |
Doron Cohen
AUD | Comptroller/Controller/Auditor | 53 | 31-08-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Doron Nevo
BRD | Director/Board Member | 68 | 29-07-18 |
Erez Meltzer
BRD | Director/Board Member | 66 | 05-07-16 |
Orit Stav
BRD | Director/Board Member | 53 | 01-11-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,70% | 42,59 mld. | |
+7,94% | 40,65 mld. | |
+49,22% | 40,57 mld. | |
-12,36% | 26,77 mld. | |
+9,02% | 24,81 mld. | |
-24,71% | 18,17 mld. | |
+28,25% | 12,05 mld. | |
-3,35% | 11,7 mld. | |
+6,93% | 11,1 mld. |